GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Core Laboratories Inc (NYSE:CLB) » Definitions » Cyclically Adjusted PS Ratio

Core Laboratories (Core Laboratories) Cyclically Adjusted PS Ratio : 0.92 (As of Apr. 27, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Core Laboratories Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Core Laboratories's current share price is $16.94. Core Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 was $18.49. Core Laboratories's Cyclically Adjusted PS Ratio for today is 0.92.

The historical rank and industry rank for Core Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

CLB's Cyclically Adjusted PS Ratio is not ranked *
in the Oil & Gas industry.
Industry Median: 0.9
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Core Laboratories's adjusted revenue per share data for the three months ended in Mar. 2023 was $2.703. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $18.49 for the trailing ten years ended in Mar. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Core Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Core Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Laboratories Cyclically Adjusted PS Ratio Chart

Core Laboratories Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.09 1.92 1.40 1.19 1.07

Core Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.64 1.05 0.68 1.07 1.19

Competitive Comparison of Core Laboratories's Cyclically Adjusted PS Ratio

For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Laboratories's Cyclically Adjusted PS Ratio Distribution in the Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Core Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Core Laboratories's Cyclically Adjusted PS Ratio falls into.



Core Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Core Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=16.94/18.49
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Core Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, Core Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=2.703/124.7200*124.7200
=2.703

Current CPI (Mar. 2023) = 124.7200.

Core Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201306 5.705 98.320 7.237
201309 5.961 99.080 7.504
201312 6.069 98.360 7.695
201403 5.819 99.390 7.302
201406 5.958 99.240 7.488
201409 6.222 99.960 7.763
201412 6.342 99.050 7.986
201503 4.915 99.750 6.145
201506 4.746 100.230 5.906
201509 4.621 100.500 5.735
201512 4.298 99.730 5.375
201603 3.614 100.310 4.493
201606 3.403 100.260 4.233
201609 3.237 100.570 4.014
201612 3.272 100.710 4.052
201703 3.531 101.440 4.341
201706 3.565 101.370 4.386
201709 3.674 102.030 4.491
201712 3.853 101.970 4.713
201803 3.824 102.470 4.654
201806 3.944 103.100 4.771
201809 4.085 103.950 4.901
201812 3.916 103.970 4.698
201903 3.782 105.370 4.477
201906 3.772 105.840 4.445
201909 3.873 106.700 4.527
201912 3.533 106.800 4.126
202003 3.429 106.850 4.002
202006 2.603 107.510 3.020
202009 2.347 107.880 2.713
202012 2.556 107.850 2.956
202103 2.358 108.870 2.701
202106 2.521 109.670 2.867
202109 2.504 110.790 2.819
202112 2.705 114.010 2.959
202203 2.490 119.460 2.600
202206 2.564 119.050 2.686
202209 2.679 126.890 2.633
202212 2.751 124.940 2.746
202303 2.703 124.720 2.703

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Core Laboratories  (NYSE:CLB) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Core Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Core Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Core Laboratories (Core Laboratories) Business Description

Industry
Traded in Other Exchanges
N/A
Address
6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Executives
Katherine Murray director 6316 WINDFERN ROAD, HOUSTON TX 77040
Mark Damian Tattoli officer: SVP, Gen Counsel & Secretary C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Kwaku Temeng director C/O CORE LABORATORIES LP, 2216 SHERIDAN STREET, HOUSTON TX 77002
Gwendolyn Schreffler officer: SVP C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Harvey Robert Klingensmith director P.O. BOX 131144, HOUSTON TX 77219-1114
Van Dijken Eeuwijk Monique director P.O. BOX 129, BILTHOVEN P7 3720 AC
Jan Willem Sodderland director DUINDISTEL 89, NOORDWIJK P7 2202 DE
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Lawrence Bruno officer: President 6316 WINDFERN ROAD, HOUSTON TX 77040
Mark F Elvig officer: VP, Counsel & Secretary 6316 WINDFERN, HOUSTON TX 77040
Gregory Barry Barnett director 853 MILWAUKEE STREET, DENVER CO 80206
Kevin Daniels officer: CAO & Treasurer 6316 WINDFERN ROAD, HOUSTON TX 77040
Michael Straughen director 68 RUBISLAW DEN NORTH, ABERDEEN X0 AB15 4AN
Martha Z. Carnes director 6316 WINDFERN ROAD, HOUSTON TX 77040